We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Fiera Capital Global Equity Class C - Accumulation (GBP)

Sell:1,600.20p Buy:1,600.20p Change: 7.50p (0.47%)
Prices as at 21 November 2024
Sell:1,600.20p
Buy:1,600.20p
Change: 7.50p (0.47%)
You can buy or sell holdings in this fund through a Stocks and Shares ISA, Lifetime ISA, SIPP or Fund and Share Account
Prices as at 21 November 2024
Sell:1,600.20p
Buy:1,600.20p
Change: 7.50p (0.47%)
Prices as at 21 November 2024
You can buy or sell holdings in this fund through a Stocks and Shares ISA, Lifetime ISA, SIPP or Fund and Share Account
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Our view on this Fund

This fund does not feature on the Wealth Shortlist of funds our analysts believe have the potential to outperform their peers over the long term. This is not a recommendation to sell; however, if you are thinking of adding to your investments, we believe the Wealth Shortlist is a good place to start. View funds on the Wealth Shortlist »

Our view on the sector

It's natural for UK investors to focus on funds investing in their home market. But as the world has become more connected, so has the investment landscape. There are lots of funds investing across the globe, and these can be a great way to diversify an investment portfolio. Funds in the global sector can invest anywhere in the world. But they go about this in different ways. They vary in how much they can invest in certain types of companies, sectors, countries, or regions. Some focus on developed markets or large multinational corporations, while others invest more in higher-risk emerging markets or smaller companies. Some target companies with higher-growth expectations and others search for unloved companies with the potential to recover.

Performance Analysis

Performance analysis for this fund is not available.

Investment Philosophy

Investment philosophy for this fund is not available.

Process and Portfolio Construction

Process and portfolio construction for this fund are not available.

question mark Manager Track Record Based on HL Quantitative Research

This information is currently unavailable.

Fund Track Record

22/11/19 to 22/11/20 22/11/20 to 22/11/21 22/11/21 to 22/11/22 22/11/22 to 22/11/23 22/11/23 to 22/11/24
Annual return 13.23% 28.36% -4.32% 6.89% 13.97%

Please remember past performance is not a guide to future returns. Where no data is shown, figures are not available. This information is provided to help you choose your own investments, remember they can fall as well as rise in value so you may not get back the original amount invested.

Information about the fund

Fund manager biography

Manager Name: Nadim Rizk
Manager start date: 1 October 2009
Manager located in: Montreal

Nadim Rizk is Head of the Global Equity team and the Lead Portfolio Manager for the US, International and Global Equity strategies. At the current time he manages over CAD 30 billion (USD 23 billion) in global equity investments across three strategies for Fiera Capital on behalf of clients worldwide. Prior to joining the firm Nadim spent over eight years as Senior Vice President and Portfolio Manager, Global Equities at Montrusco Bolton. He has held Senior Global Research Analyst positions at some of Canada's leading investment management firms. He began his career in financial services in 1997 and has over 20 year's industry experience. Nadim holds a BBA majoring in Finance from American University of Beirut, an MBA from McGill University and is a CFA Charterholder. Nadim and the Global Equity team hold multiple awards over several years including Morningstar's 5-star and Fundata's FundGrade A+ ratings for Fiera Capital's Global and US Equity Funds. Nadim serves on the Board of Directors of Cedars Cancer Foundation, a hospital-based charity whose mission is to improve the health and well-being of cancer patients of all ages and their families.

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Benchmark data provided subject to this disclaimer.
You can buy or sell holdings in this fund through a Stocks and Shares ISA, Lifetime ISA, SIPP or Fund and Share Account